---
schema_version: "secwatch.filing_event.v1"
accession: "0000926326-26-000003"
form_type: "8-K"
ticker: "OMCL"
cik: "0000926326"
company_name: "OMNICELL, INC."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:44:52.937733+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Omnicell Q4 rev $314M (+2% YoY), GAAP net loss $0.05/sh; FY26 revenue guide $1.215-1.255B

## Summary
- Q4 total revenues $314M (+2% YoY); full-year 2025 rev $1.185B (+7% YoY).
- GAAP net loss Q4 $2M ($0.05 diluted loss) vs net income $16M ($0.34) in Q4 2024.
- Non-GAAP net income Q4 $18M ($0.40) vs $28M ($0.60) YoY; FY25 non-GAAP EPS $1.62.
- FY2025 product bookings $535M (-4% YoY); ARR $635.6M (+9.6%); product backlog $640.3M.
- Launched Titan XT dispensing system at ASHP Midyear; guides FY26 rev $1.215-1.255B, Non-GAAP EBITDA $145-160M.

## SEC filing metadata
- accession: 0000926326-26-000003
- form_type: 8-K
- ticker: OMCL
- cik: 0000926326
- company_name: OMNICELL, INC.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926326/000092632626000003/0000926326-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926326/000092632626000003/omcl-20260205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926326-26-000003
- JSON: https://secwatch.observer/filing/0000926326-26-000003.json
- Plain text: https://secwatch.observer/filing/0000926326-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.